Phase Ib Dose-escalation Trial of Taselisib (GDC-0032) in Combination With Anti-HER2 Therapies in Participants With Advanced HER2+ Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
A Study of Palbociclib in Combination With Fulvestrant or Tamoxifen as Treatment for Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Fulvestrant as Maintenance Therapy After First-line Chemotherapy in HER2 - Postmenopausal MBC Patients
- Status
- UNKNOWN
- Phase
- PHASE3
A Double-blind Study of Paclitaxel in Combination With Reparixin or Placebo for Metastatic Triple-Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Observation of Medical Treatments in MBC HER2-negative Patients
- Status
- UNKNOWN
- Phase
- N/A
Evaluation of Icotinib in Metastatic Triple-negative Breast Cancer After Second-line Therapy
- Status
- TERMINATED
- Phase
- PHASE2
Study Evaluating Pyrotinib in Combination With Capecitabine In Patients With HER2 Positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of GnRH-A [Leuprorelin(Lorelin Depot] Plus Leterozole +/- Everolimus for Premenopausal Women With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Detect V / CHEVENDO (Chemo vs. Endo)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of ASLAN001 in Combination With Capecitabine in MBC That Has Failed on Prior Trastuzumab
- Status
- COMPLETED
- Phase
- PHASE2
Prospective Study of VEGFR-2 /IL-8 Genetic Interaction in MBC Treated With Paclitaxel and Bevacizumab vs. Chemotherapy
- Status
- COMPLETED
- Phase
- N/A
A Multicenter Trial Assessing the Efficacy and Safety of tamOxifen Plus LY2228820 in Advanced or Metastatic Breast Cancer Progressing on aromatasE Inhibitors
- Status
- TERMINATED
- Phase
- PHASE2
Real-World Outcome Research Study on Quality of Life, Work Productivity and Health Care Resource Utilization in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
Everolimus trIal for Advanced prememopausaL Breast Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Trial of Active Immunotherapy With OBI-833 (Globo H-CRM197) in Advanced/Metastatic Gastric, Lung, Colorectal or Breast Cancer Subjects
- Status
- COMPLETED
- Phase
- PHASE1
SAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Evaluation of Medical Treatments in MBC Patients According Biological Subtype and Line of Treatments
- Status
- RECRUITING
- Phase
- N/A
Eribulin Plus Gemcitabine (EG) vs Paclitaxel Plus Gemcitabine (PG) in HER2-Negative Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Evolution of Resistance to Systemic Therapies in Patients With Breast Cancer
- Status
- TERMINATED
- Phase
- N/A
Safety and QoL of Trastuzumab With Lapatinib or Chemiotherapy in MBC and HER2+ Patients Refractory to Anti HER2 Therapies
- Status
- UNKNOWN
- Phase
- PHASE2